Nextech-Invest-Ltd

Filing Details

13F-HR2024-12-31
Report Date
2024-12-31
Filing Date
2025-02-14
Total Holdings
15
Total Value
616414127
Accession Number
0001104659-25-014109
Form Type
13F-HR
Manager Name
Nextech-Invest-Ltd
Data Enrichment
100% identified
15 identified0 unidentified

Holdings

15 positions • $616.4M total value
Manager:
Search and click to pin securities to the top
Revolution Medicines, Inc.
Shares:7.6M
Value:$332.5M
% of Portfolio:53.9% ($332.5M/$616.4M)
Tyra Biosciences, Inc.
Shares:4.1M
Value:$56.4M
% of Portfolio:9.1% ($56.4M/$616.4M)
Oric Pharmaceuticals, Inc.
Shares:5.3M
Value:$42.7M
% of Portfolio:6.9% ($42.7M/$616.4M)
CARGO Therapeutics, Inc.
Shares:2.6M
Value:$38.1M
% of Portfolio:6.2% ($38.1M/$616.4M)
ARVINAS, INC.
Shares:1.4M
Value:$27.0M
% of Portfolio:4.4% ($27.0M/$616.4M)
Mersana Therapeutics, Inc.
Shares:12.1M
Value:$17.3M
% of Portfolio:2.8% ($17.3M/$616.4M)
Tango Therapeutics, Inc.
Shares:5.5M
Value:$17.1M
% of Portfolio:2.8% ($17.1M/$616.4M)
Zymeworks Inc.
Shares:1.1M
Value:$16.3M
% of Portfolio:2.6% ($16.3M/$616.4M)
Relay Therapeutics, Inc.
Shares:3.8M
Value:$15.8M
% of Portfolio:2.6% ($15.8M/$616.4M)
Cullinan Therapeutics, Inc.
Shares:1.1M
Value:$13.9M
% of Portfolio:2.3% ($13.9M/$616.4M)
ALUMIS INC.
Shares:1.5M
Value:$11.6M
% of Portfolio:1.9% ($11.6M/$616.4M)
ARS Pharmaceuticals, Inc.
Shares:936.7K
Value:$9.9M
% of Portfolio:1.6% ($9.9M/$616.4M)
Context Therapeutics Inc.
Shares:7.4M
Value:$7.8M
% of Portfolio:1.3% ($7.8M/$616.4M)
Silence Therapeutics plc
Shares:952.4K
Value:$6.6M
% of Portfolio:1.1% ($6.6M/$616.4M)
Boundless Bio, Inc.
Shares:1.2M
Value:$3.6M
% of Portfolio:0.6% ($3.6M/$616.4M)